← Latest papers
📄 psychiatry and clinical psychology

Facial Emotion Processing and GABAergic Modulation in Individuals at Clinical High-Risk for Psychosis

This study demonstrates that individuals at clinical high-risk for psychosis exhibit altered neural processing of neutral facial expressions with elevated amygdala and hippocampal activation, and suggests that GABAergic enhancement via diazepam may modulate specific aspects of emotion processing and midcingulate cortex activity.

Original authors: Julius, N. C., Lukow, P. B., Kiemes, A., Livingston, N. R., Avram, M.-M., Knight, S. R., Hawkins, P. C., O'Daly, O., Jelen, L., Reilly, T. J., Dima, A., Nettis, M. A., Casetta, C., Vorontsova, N., Dav
Published 2026-11-16
📖 5 min read🧠 Deep dive

Original authors: Julius, N. C., Lukow, P. B., Kiemes, A., Livingston, N. R., Avram, M.-M., Knight, S. R., Hawkins, P. C., O'Daly, O., Jelen, L., Reilly, T. J., Dima, A., Nettis, M. A., Casetta, C., Vorontsova, N., Davies, J., Wall, M. B., Spencer, T. J., de Micheli, A., Fusar-Poli, P., Grace, A. A., Ruparel, K., Gur, R. C., Zelaya, F., Williams, S. C., McGuire, P., Turkheimer, F., Mehta, M. A., Chesney, E., Modinos, G.

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

The human brain is a complex machine for interpreting the world, but for some people, the machinery for reading social cues begins to stutter long before a full-blown mental illness takes hold. This early warning stage, known as clinical high-risk for psychosis, is a period where individuals experience subtle changes in their thinking and perception, putting them on a path that might lead to conditions like schizophrenia. A key feature of this risk is a struggle to understand the emotions on other people's faces. While most of us can instantly tell if a stranger is angry, happy, or neutral, those at risk often find this task confusing or slow. Scientists believe this difficulty stems from a chemical imbalance in the brain's emotional centers, specifically involving a neurotransmitter called GABA, which acts as a brake to calm overactive neural signals. If this braking system is faulty, the brain might misinterpret a neutral face as a threat, or fail to process a real threat correctly. Understanding exactly how this chemical system works in the early stages of risk could offer a new way to intervene before the illness becomes severe.

To investigate this, researchers conducted two linked studies involving young adults who were at high risk for developing psychosis but had never taken medication for mental health conditions. In the first study, they asked these individuals and a group of healthy volunteers to perform a facial emotion recognition task while inside a brain scanner. The participants looked at images of faces showing anger, fear, happiness, sadness, or a neutral expression, and had to identify the emotion as quickly as possible. The researchers were looking for differences in how fast the participants reacted and which parts of their brains lit up during the task. They found that while the accuracy of the answers was similar between the two groups, the individuals at high risk took significantly longer to make their decisions. More importantly, their brains reacted differently to the images. When looking at neutral faces, the high-risk group showed heightened activity in deep brain structures known as the amygdala and hippocampus, areas usually associated with processing fear and memory. Conversely, when viewing faces that clearly showed a threat, such as anger or fear, these same brain regions showed less activity than in the healthy volunteers. This pattern suggests that the high-risk group was over-reacting to ambiguous, neutral expressions while under-reacting to clear emotional signals, essentially treating a blank face as if it were a warning sign.

The second study sought to see if this chemical imbalance could be temporarily corrected. The same group of high-risk individuals returned for a new experiment where they took a small dose of diazepam, a medication known to boost the activity of GABA, the brain's calming chemical. They took the drug on one visit and a placebo on another, in a random order, and repeated the facial recognition task while being scanned. The researchers hoped that by strengthening the brain's natural braking system, the drug would help the participants process emotions more normally. The results were mixed. The medication did not significantly change how fast or how accurately the participants identified emotions in the main analysis. However, when the researchers looked more closely at the brain scans, they found that the drug did change how a specific area called the midcingulate cortex responded to neutral faces. This region, which helps the brain decide what is important, showed reduced activity under the influence of the drug when viewing neutral expressions. This suggests that while a single dose of the medication did not completely fix the behavioral symptoms, it did alter the brain's response to ambiguous social cues, hinting that the GABA system plays a role in how these individuals process the world around them.

The findings paint a picture of a brain that is working harder to decode social signals, particularly when those signals are unclear. The individuals at risk were not necessarily worse at recognizing emotions in terms of getting the right answer, but the process took more time and energy, and their brains were firing up in response to faces that carried no emotional weight. The study also ruled out the idea that a simple dose of diazepam would immediately normalize these complex social processing deficits. While the drug did not produce a dramatic improvement in behavior, the fact that it changed brain activity in a specific region involved in salience and attention offers a glimmer of hope. It suggests that the neural circuits responsible for these difficulties are sensitive to chemical modulation. The research highlights that the struggle for these individuals is not just about seeing a face, but about how their brains assign meaning to the silence between expressions. By focusing on these subtle neural shifts, scientists are beginning to map the early terrain of psychosis risk, looking for ways to help the brain find its balance before the storm breaks.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →